Research map: The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches

Back to the article

Papers in this map

  1. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells · Hadi Valadi · 2007 · 13108 citations · Cited by this paper
  2. The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma · 2026 · Related
  3. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines · Clotilde Théry · 2018 · 11543 citations · Cited by this paper
  4. Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials · 2026 · Related
  5. Circulating microRNAs as stable blood-based markers for cancer detection · Patrick S. Mitchell · 2008 · 8044 citations · Cited by this paper
  6. Portal vein resection in pancreatic cancer: from technical feasibility to biological patient selection · 2026 · Related
  7. Non-coding RNAs in human disease · Manel Esteller · 2011 · 4951 citations · Cited by this paper
  8. The evolving survival landscape in advanced non-small cell lung cancer: an interrupted time series analysis · 2026 · Related
  9. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma · Samuel A. Wells · 2015 · 2458 citations · Cited by this paper
  10. Angiosarcoma: adaptive designs leveraging vascular biology and antiangiogenic repurposing · 2026 · Related
  11. Liquid Biopsies: Genotyping Circulating Tumor DNA · Luis Alberto Diaz · 2014 · 2244 citations · Cited by this paper
  12. Quantitative and qualitative fecal immunochemical tests for colorectal cancer screening in Kazakhstan: a comparative study · 2026 · Related
  13. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles · Bence György · 2011 · 2106 citations · Cited by this paper
  14. Frailty is not ECOG: why performance status alone is no longer enough in anticancer therapy · 2026 · Related
  15. Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells · Nobuyoshi Kosaka · 2010 · 1983 citations · Cited by this paper
  16. Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B? · 2026 · Related
  17. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA · M.C. Liu · 2020 · 1574 citations · Cited by this paper
  18. Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19–9 undergoing pancreatic ductal adenocarcinoma resection · 2026 · Related
  19. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy · Catherine Alix‐Panabières · 2016 · 1425 citations · Cited by this paper
  20. Cancer genome profiling in sarcomas: current status and future perspectives in Japan · 2026 · Related
  21. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers · Iñigo Landa · 2016 · 1326 citations · Cited by this paper
  22. The changing incidence of thyroid cancer · Cari Meinhold Kitahara · 2016 · 1095 citations · Cited by this paper
  23. Screening for Thyroid Cancer · Jennifer S Lin · 2017 · 1092 citations · Cited by this paper
  24. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer · Thomas Reinert · 2019 · 1054 citations · Cited by this paper
  25. Biologic and Clinical Perspectives on Thyroid Cancer · James A. Fagin · 2016 · 1019 citations · Cited by this paper
  26. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer · Christian Diego Rolfo · 2021 · 684 citations · Cited by this paper
  27. Thyroid cancer incidence trends by histology in 25 countries: a population-based study · Adalberto Miranda‐Filho · 2021 · 624 citations · Cited by this paper
  28. Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth · Takayuki Kogure · 2011 · 548 citations · Cited by this paper
  29. Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies · Robert C. Smallridge · 2010 · 486 citations · Cited by this paper
  30. RNA in extracellular vesicles · Kyoung Mi Kim · 2017 · 465 citations · Cited by this paper
  31. Progress in Ion Torrent semiconductor chip based sequencing · Barry Merriman · 2012 · 361 citations · Cited by this paper
  32. Non‐coding RNAs: Meet thy masters · Fabrício Falconi Costa · 2010 · 324 citations · Cited by this paper
  33. DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate Cancer · Martina Tinzl · 2004 · 284 citations · Cited by this paper
  34. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer · Xiaoying Zhou · 2015 · 217 citations · Cited by this paper
  35. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer · Maria A. Papadaki · 2018 · 214 citations · Cited by this paper
  36. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma · Jun Li · 2015 · 213 citations · Cited by this paper
  37. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma · Bin Xu · 2016 · 199 citations · Cited by this paper
  38. Thyroid Cancer: Burden of Illness and Management of Disease · Rebecca L. Brown · 2011 · 188 citations · Cited by this paper
  39. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer · Sina Halvaei · 2017 · 188 citations · Cited by this paper

Source: OpenAlex (CC0)